MYELOID NEOPLASM
Clinical trials for MYELOID NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new MYELOID NEOPLASM trials appear
Sign up with your email to follow new studies for MYELOID NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail shows promise for Hard-to-Treat leukemia
Disease control OngoingThis study tests a combination of three drugs (azacitidine, venetoclax, and pevonedistat) in adults with a newly diagnosed, aggressive form of acute myeloid leukemia (AML) that is either related to prior cancer treatment or developed from other blood disorders. The goal is to fin…
Matched conditions: MYELOID NEOPLASM
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 05:55 UTC
-
New hope for AML patients: stronger chemo may work in Less-Fit adults
Disease control OngoingThis study tests whether giving full-strength chemotherapy (either CPX-351 or a combination called CLAG-M) can improve survival in adults with acute myeloid leukemia who are not healthy enough for standard intensive treatment. About 60 participants will be randomly assigned to on…
Matched conditions: MYELOID NEOPLASM
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
New combo therapy aims to stop leukemia growth in High-Risk patients
Disease control OngoingThis large phase 3 trial tests whether adding bortezomib and sorafenib to standard chemotherapy helps people with newly diagnosed acute myeloid leukemia (AML) live longer without the cancer returning. The study includes over 1,600 participants and focuses on those with a specific…
Matched conditions: MYELOID NEOPLASM
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
Promising drug aims to clear cancer before transplant in kids and teens
Disease control OngoingThis study tests an investigational drug called CPX-351 in 25 people under 22 years old who have secondary myeloid neoplasms (cancers that develop after prior cancer treatment). The goal is to see if one or two rounds of CPX-351 can achieve complete remission (no detectable cance…
Matched conditions: MYELOID NEOPLASM
Phase: PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated May 19, 2026 12:00 UTC